EVAXION BIOTECH A S's ticker is EVAX and the CUSIP is 29970R105. A total of 10 filers reported holding EVAXION BIOTECH A S in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,871 | -36.4% | 3,446 | 0.0% | 0.00% | – |
| Q2 2023 | $4,514 | -89.0% | 3,446 | -90.5% | 0.00% | – |
| Q1 2023 | $40,946 | +524.2% | 36,235 | +880.4% | 0.00% | – |
| Q4 2022 | $6,560 | -34.4% | 3,696 | 0.0% | 0.00% | – |
| Q3 2022 | $10,000 | +25.0% | 3,696 | -14.0% | 0.00% | – |
| Q2 2022 | $8,000 | -69.2% | 4,296 | -48.6% | 0.00% | – |
| Q1 2022 | $26,000 | +62.5% | 8,357 | +126.1% | 0.00% | – |
| Q4 2021 | $16,000 | +700.0% | 3,696 | +1748.0% | 0.00% | – |
| Q3 2021 | $2,000 | +100.0% | 200 | +100.0% | 0.00% | – |
| Q1 2021 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 122,000 | $238,000 | 0.28% |
| CITIGROUP INC | 2,941 | $6,000 | 0.00% |
| MORGAN STANLEY | 4,296 | $8,000 | 0.00% |
| Citadel Advisors | 333,100 | $650,000 | 0.00% |
| Citadel Advisors | 37,300 | $73,000 | 0.00% |
| Citadel Advisors | 83,586 | $163,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 192,800 | $376,000 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 339 | $1,000 | 0.00% |
| Steward Partners Investment Advisory, LLC | 1,000 | $2,000 | 0.00% |
| Renaissance Technologies | 11,600 | $22,000 | 0.00% |